Activation of GLP-1R also triggers the PI3K/Akt signaling pathway via the subunits of G proteins, thereby promoting -cell viability and replicative capacity ( 2.2 Inflammation and immune modulation Recent preclinical studies have demonstrated its bidirectional immunomodulatory effects, including improvement of organ dysfunction, regulation of immune responses, and mitigation of sepsis-associated cytokine storms, mediated through anti-inflammatory and anti-apoptotic pathways
GLP-1RA therapy was initially developed to treat type 2 diabetes
Who should take these medications
However, this persistent effect also means tirzepatide may reduce the adaptive metabolic response that intermittent fasting traditionally triggers, potentially limiting some of fasting's cellular benefits like autophagy activation
Approximately 5% of individuals stopped taking the medication because of negative reactions, and easing symptoms may be achieved by slowly decreasing the dosage (Sanchez-Rangel and Inzucchi, 2017